Subscribe to our newsletter to receive the latest product updates and special offers

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

New on Charts:

We've added Splits, Dividends, Earnings, and Earnings Estimates! Click on individual events to unveil more details.

If you prefer a cleaner view, easily disable them in Settings.

NVAX | Novavax, Inc.

IndexRUT P/E- EPS (ttm)-7.27 Insider Own7.24% Shs Outstand94.40M Perf Week1.95%
Market Cap691.95M Forward P/E- EPS next Y-0.95 Insider Trans0.00% Shs Float87.57M Perf Month-19.01%
Income-586.76M PEG- EPS next Q-1.33 Inst Own61.24% Short Float / Ratio50.81% / 4.68 Perf Quarter3.82%
Sales1.60B P/S0.43 EPS this Y80.34% Inst Trans4.89% Short Interest44.50M Perf Half Y-0.14%
Book/sh-8.00 P/B- EPS next Y42.50% ROA-27.24% Target Price21.40 Perf Year-60.59%
Cash/sh5.47 P/C1.34 EPS next 5Y- ROE- 52W Range5.61 - 25.66 Perf YTD-28.70%
Dividend- P/FCF- EPS past 5Y7.76% ROI- 52W High-71.43% Beta1.70
Dividend %- Quick Ratio0.69 Sales past 5Y525.36% Gross Margin56.08% 52W Low30.78% ATR0.66
Employees1992 Current Ratio0.71 Sales Q/Q128.28% Oper. Margin-38.42% RSI (14)46.77 Volatility9.54% 9.17%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin-36.73% Rel Volume1.46 Prev Close7.67
ShortableYes LT Debt/Eq- EarningsAug 08 BMO Payout- Avg Volume9.50M Price7.33
Recom2.50 SMA20-4.49% SMA50-7.05% SMA200-13.13% Volume13,904,465 Change-4.43%
Date Action Analyst Rating Change Price Target Change
Aug-09-23Upgrade B. Riley Securities Neutral → Buy $15
Apr-20-23Downgrade TD Cowen Outperform → Market Perform $55 → $10
Mar-01-23Downgrade B. Riley Securities Buy → Neutral $29 → $10
Jan-09-23Reiterated B. Riley Securities Buy $74 → $37
Dec-30-22Reiterated H.C. Wainwright Buy $207 → $110
Dec-02-22Initiated Jefferies Hold
Sep-22-22Downgrade JP Morgan Neutral → Underweight $132 → $27
May-20-22Initiated BofA Securities Underperform $35
Feb-23-22Reiterated B. Riley Securities Buy $315 → $265
Feb-22-22Resumed Jefferies Buy $198
Today 02:51PM
02:30PM
01:37PM
11:38AM
11:19AM
09:41AM Loading…
09:41AM
07:18AM
Oct-03-23 04:47PM
04:36PM
04:36PM
04:18PM
04:01PM
03:50PM
03:50PM
03:31PM
03:12PM Loading…
03:12PM
03:11PM
02:42PM
02:40PM
11:29AM
Sep-28-23 01:11PM
Sep-26-23 01:30PM
Sep-25-23 01:34PM
Sep-21-23 09:39AM
07:30AM
Sep-19-23 01:13PM
Sep-15-23 09:35AM
Sep-14-23 09:37AM
05:00AM
Sep-13-23 10:07AM
08:12AM Loading…
08:12AM
04:51AM
Sep-12-23 05:22PM
02:03PM
10:26AM
09:33AM
06:00AM
Sep-11-23 04:03PM
02:12PM
02:07PM
Sep-08-23 04:31PM
12:24PM
12:00PM
Sep-07-23 11:55AM
11:31AM
11:20AM
Sep-06-23 01:16PM
01:06PM
05:30AM
Sep-05-23 08:59PM
12:10PM
Sep-01-23 06:15AM
Aug-31-23 10:33AM
10:07AM
09:27AM
Aug-30-23 07:29PM
Aug-29-23 07:30AM
Aug-28-23 06:16PM
Aug-27-23 06:10AM
Aug-25-23 09:16AM
06:08AM
Aug-24-23 10:15AM
Aug-23-23 10:32AM
08:27AM
05:00AM
Aug-22-23 04:46PM
12:30PM
10:29AM
10:25AM
07:29AM
07:12AM
07:00AM
Aug-21-23 04:50PM
04:27PM
04:18PM
Aug-18-23 04:05PM
01:30PM
Aug-17-23 10:14AM
09:45AM
Aug-14-23 12:44PM
Aug-11-23 08:50AM
Aug-10-23 06:48PM
09:15AM
Aug-09-23 06:35PM
10:37AM
Aug-08-23 04:56PM
02:55PM
10:32AM
10:30AM
10:15AM
09:11AM
08:18AM
08:00AM
06:55AM
06:37AM
04:44AM
Aug-07-23 11:32AM
Aug-04-23 09:21AM
Aug-03-23 12:25PM
Aug-01-23 09:25AM
Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.
Insider Trading Relationship Date Transaction Cost #Shares Value ($) #Shares Total SEC Form 4
Dubovsky FilipPresident, R&DSep 16Option Exercise7.7112,64497,48557,702Sep 19 05:16 PM
Dubovsky FilipPresident, R&DJun 16Option Exercise8.044,15533,40647,065Jun 21 04:40 PM
Glenn Gregory MPresident, R&DMar 10Option Exercise6.526,29841,06320,771Mar 14 05:16 PM
Trizzino JohnEVP, CCO and CBOMar 10Option Exercise6.524,60930,05111,531Mar 14 05:20 PM
Kelly James PatrickEVP, CFO and TreasurerMar 10Option Exercise6.524,60930,0515,832Mar 14 05:19 PM
Herrmann John A IIIEVP, Chief Legal OfficerMar 10Option Exercise6.524,60930,05113,058Mar 14 05:18 PM
Glenn Gregory MPresident, R&DMar 10Buy6.501,0006,50014,473Mar 14 05:16 PM
Glenn Gregory MPresident, R&DMar 07Buy7.042,00014,08813,473Mar 14 05:16 PM
Glenn Gregory MPresident, R&DMar 06Buy7.483,00022,45411,473Mar 14 05:16 PM